Cited by 180Mechanical Circulatory Support DevicesCongenital Heart Disease StudiesCardiac and Coronary Surgery Techniques

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Extracorporeal membrane oxygenation in postcardiotomy patients: Factors influencing outcome

Open access

Abstract

Objective Our objective was to assess the morbidity and mortality in children requiring extracorporeal membrane oxygenator support after cardiac surgery and to determine factors influencing outcome. Methods Between January 2003 and June 2008, 58 patients required extracorporeal membrane oxygenator support after cardiac surgery. A retrospective study was performed and factors influencing outcome were determined by logistic regression modeling with the probability of outcome based on a combination of multivariate predictors. Results Median age and weight were 12 days and 3.3 kg, respectively. Thirty-one patients had single ventricle repair and 27 had biventricular repair. Median duration of support with the oxygenator was 6 days. Thirty-nine (67%) patients were successfully weaned off the support, but only 24 (41%) survived to hospital discharge. Chief complications were renal failure (31%), neurologic complications (29%), and sepsis (16%). Multivariable logistic regression analysis identified 10 days or more of extracorporeal membrane oxygenation (odds ratio = 6.1), urine output less than 2 mL x kg(-1) x h(-1) in first 24 hours (odds ratio = 15), renal failure (odds ratio = 9.4), and pH less than 7.35 after 24 hours of extracorporeal membrane oxygenation (odds ratio = 82) as significant independent factors associated with failure to wean off extracorporeal membrane oxygenation. Factors associated with failure of hospital discharge despite successful decannulation were as follows: extracorporeal membrane oxygenator support time of 10 days or more, red blood cell transfusion of greater than 1000 mL/kg during the entire period of oxygenator support, and sepsis. Patients with single ventricle repair were at higher risk of hospital mortality. Conclusion Longer duration of extracorporeal membrane oxygenator support, low pH and urine output in the first 24 hours, and renal failure are significant factors associated with mortality during extracorporeal membrane oxygenator support. Exposure to high amounts of blood transfusion during extracorporeal oxygenation, extended extracorporeal membrane oxygenator support, and sepsis increase risk of death after successful decannulation.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.jtcvs.2010.02.034

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Progressive low cardiac output syndrome is the cause for 36% of post-operative extracorporeal life support cannulations, making it one of the most common indications for extracorporeal life support in the post-operative period.

    “Progressive LCOS is the cause for 36% of post-operative ECLS cannulations, making it one of the most common indications for ECLS in the post-operative period [28-32].”
  • Survival of pediatric patients who receive extracorporeal life support after cardiac surgery is approximately 41-49%.

    “Survival of pediatric patients who receive ECLS after cardiac surgery is approximately 41-49% [28-32].”

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 22

  1. Aharon, 2001, Extracorporeal membrane oxygenation in children after repair of congenital cardiac lesions, Ann Thorac Surg, 72, 2095, 10.1016/S0003-4975(01)03209-X · DOI
  2. Morris, 2004, Risk factors for mortality in 137 pediatric cardiac intensive care unit patients managed with extracorporeal membrane oxygenation, Crit Care Med, 32, 1061, 10.1097/01.CCM.0000119425.04364.CF · DOI
  3. Duncan, 1999, Mechanical circulatory support in children with cardiac disease, J Thorac Cardiovasc Surg, 117, 529, 10.1016/S0022-5223(99)70333-8 · DOI
  4. Balasubramanian, 2007, Factors influencing the outcome of paediatric cardiac surgical patients during extracorporeal circulatory support, J Cardiothorac Surg, 2, 4, 10.1186/1749-8090-2-4 · DOI
  5. Kolovos, 2003, Outcome of pediatric patients treated with extracorporeal life support after cardiac surgery, Ann Thorac Surg, 76, 1435, 10.1016/S0003-4975(03)00898-1 · DOI
  6. Baslaim, 2006, Can the outcome of pediatric extracorporeal membrane oxygenation after cardiac surgery be predicted?, Ann Thorac Cardiovasc Surg, 12, 21
  7. Shah, 2005, Clinical outcomes of 84 children with congenital heart disease managed with extracorporeal membrane oxygenation after cardiac surgery, ASAIO J, 51, 504, 10.1097/01.mat.0000171595.67127.74 · DOI
  8. Jaggers, 2000, Extracorporeal membrane oxygenation for infant postcardiotomy support: significance of shunt management, Ann Thorac Surg, 69, 1476, 10.1016/S0003-4975(00)01330-8 · DOI
  9. Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 · DOI · Paper page
  10. Harrell, 1996, Multivariate prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors, Stat Med, 15, 361, 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4 · DOI
  11. Baffes, 1970, Extracorporeal circulation for support of palliative cardiac surgery in infants, Ann Thorac Surg, 10, 354, 10.1016/S0003-4975(10)65613-5 · DOI
  12. De Angeli, 1994, The effects of prolonged cardiopulmonary bypass on cell-mediated immunity, Thorac Cardiovasc Surg, 42, 14, 10.1055/s-2007-1016447 · DOI
  13. Markewitz, 1996, An imbalance in T-helper cell subsets alters immune response after cardiac surgery, Eur J Cardiothorac Surg, 10, 61, 10.1016/S1010-7940(96)80267-3 · DOI
  14. Hadley, 2007, Alterations in inflammatory capacity and TLR expression on monocytes and neutrophils after cardiopulmonary bypass, Shock, 27, 466, 10.1097/01.shk.0000245033.69977.c5 · DOI
  15. Tanzi, 2005, Bioactive technologies for hemocompatibility, Expert Rev Med Dev, 2, 473, 10.1586/17434440.2.4.473 · DOI
  16. Deptula, 2006, Evaluation of biocompatible cardiopulmonary bypass circuit use during pediatric open heart surgery, J Extra Corpor Technol, 38, 22, 10.1051/ject/200638022 · DOI
  17. Wendel, 1999, Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation, Eur J Cardiothorac Surg, 16, 342, 10.1016/S1010-7940(99)00210-9 · DOI
  18. Valdés Xenia, 2006, Risk of blood transfusion in cardiac surgery, Arch Cardiol Mex, 76, S86
  19. Lequier, 2008, Western Canadian Complex Pediatric Therapies Program Follow-up Group. Two-year survival, mental, and motor outcomes after cardiac extracorporeal life support at less than five years of age, J Thorac Cardiovasc Surg, 136, 976, 10.1016/j.jtcvs.2008.02.009 · DOI · Paper page
  20. Montgomery, 2000, Impact of multiple organ system dysfunction and nosocomial infections on survival of children treated with extracorporeal membrane oxygenation after heart surgery, Crit Care Med, 28, 526, 10.1097/00003246-200002000-00040 · DOI
  21. Székely, 2009, Risks and predictors of blood transfusion in pediatric patients undergoing open heart operations, Ann Thorac Surg, 87, 187, 10.1016/j.athoracsur.2008.09.079 · DOI
  22. Terry, 2005, A description of a prototype miniature extracorporeal membrane oxygenation circuit using current technologies in a sheep model, J Extra Corpor Technol, 37, 315, 10.1051/ject/200537315 · DOI

Cited by

Sorted by citations

Metadata

Authors
Kumar, T. K. S., Zurakowski, D., Dalton, H., Talwar, S., Allard-Picou, A., Duebener, L. F., Sinha, P., & Moulick, A.
Affiliations
Children's National (US)
Corresponding author
Moulick, Achintya
Venue
The Journal of Thoracic and Cardiovascular Surgery
Publisher
Elsevier BV
Published
2010-08
Volume
140
Issue
2
Pages
330-336.e2
ISSN
0022-5223 (ISSN-L)
OpenAlex
W2071922723
Cited by
180
References
1
Citations by year
2026: 3 · 2025: 2 · 2024: 7 · 2023: 10 · 2022: 12 · 2021: 11 · 2020: 14 · 2019: 14 · 2018: 12 · 2017: 18 · 2016: 16 · 2015: 14 · 2014: 18 · 2013: 10 · 2012: 9
FWCI
5.01
Type
journal article
Language
en
Open access
Locations
  • Journal of Thoracic and Cardiovascular Surgery (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Mechanical Circulatory Support Devices
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Congenital Heart Disease Studies
  • Health Sciences › Medicine › Surgery › Cardiac and Coronary Surgery Techniques
Keywords
extracorporeal membrane oxygenation, pediatric cardiac surgery, single ventricle repair, biventricular repair, renal failure, sepsis, acidosis, urine output, red blood cell transfusion, ECMO weaning, mortality, decannulation
MeSH terms
Blood Transfusion, Female, Heart Defects, Congenital, Cardiac Surgical Procedures, Humans, Hydrogen-Ion Concentration, Infant, Infant, Newborn, Male, Patient Discharge, Postoperative Care, Retrospective Studies, Risk Factors, Time Factors, Urination, Extracorporeal Membrane Oxygenation, Logistic Models, Odds Ratio, Treatment Outcome, Hospital Mortality, Risk Assessment, Sepsis, Renal Insufficiency, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review